×

At the Hospitals: Dartmouth Researchers to Receive $5.3 Million to Study Treatment of Opioid Use in Pregnant Women


Friday, June 08, 2018
Dartmouth Researchers to Receive $5.3 Million to Study Treatment of Opioid Use in Pregnant Women

Hanover — A research team at Dartmouth’s Geisel School of Medicine will receive $5.3 million from the Patient-Centered Outcomes Research Institute to study medication-assisted treatment for pregnant women with opioid use disorders. 

Medication-assisted treatment (MAT) — which combines maintenance medication with psychosocial services — has been shown to significantly reduce risk for pregnant women who abuse opioids. However, it can be difficult for pregnant women to find MAT providers, so a growing number of maternity care providers to prescribe MAT in their own practices. Other providers follow the traditional approach of referring patients to specialty MAT programs.

For the five-year project, the team will compare the outcomes of these two models of care.

“Our research questions reflect what women affected by opioid use disorder and their care providers indicated as most important to them,” Sarah Lord, who is leading the research team along with Daisy Goodman, said in a news release. 

“We are interested in whether integrated care models, where women receive maternity care and treatment for (opioid addiction) together in the same practice, are more effective than models where women receive maternity care from one practice and are referred to [opioid addiction] treatment at another location,” she said. 

The two models have not been directly compared before. 

“We’re hoping the results of our study will inform both practice and policy with regard to services for women and their infant children,” Lord said.